Home / Share Price Target / Carerating
CARE Ratings Share Price Target 2024, 2025, 2026 to 2039 With Charts
CARE Ratings Limited | |||
Symbol: CARERATING | |||
Price: ₹1,426.25 | |||
Exchange: NSE | |||
Financial Services -> Financial Data & Stock Exchanges |
Show Table of Contents
Table of Contents
- 1: CARE Ratings Brief Company Overview
- 1.1: CARE Ratings Limited: A Leading Credit Rating Agency
- 1.2: CARE Ratings Financial Performance
- 1.2.1: Is CARE Ratings A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: CARE Ratings Share Price Target For 2024
- 2.1.1: CARE Ratings Share Price Target Table For 2024
- 2.1.2: Summary: CARE Ratings Share Price Prediction For 2024
- 2.2: CARE Ratings Share Price Target For 2025
- 2.2.1: CARE Ratings Share Price Target Table For 2025
- 2.2.2: Summary: CARE Ratings Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: CARE Ratings Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: CARE Ratings Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: CARE Ratings Past Performance
CARE Ratings Brief Company Overview
CARE Ratings Limited: A Leading Credit Rating Agency
Established in 1993, CARE Ratings Limited is a reputed credit rating agency in India, Mauritius, and Nepal. Recognized for its comprehensive rating and grading services, CARE plays a crucial role in the financial markets.
Key Services:
- Rating services for financial instruments, structured finance, and insurance
- Infrastructure sector ratings, security receipts, and real estate
- Corporate governance ratings, project finance, and MLD valuation
- Advisory services, research, and analytics
Diverse Product Range: CARE offers a wide range of services catering to the needs of corporates, financial institutions, banks, and institutional investors.
Commitment: CARE is committed to providing unbiased, transparent, and accurate credit ratings to facilitate informed decision-making in the financial markets.
Advertisement
CARE Ratings Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 4,446.22 Crore | Market valuation of CARE Ratings's shares. |
Revenue (TTM) | 365.11 Crore | Total revenue generated by CARE Ratings over the past twelve months. |
Net Income (TTM) | +114.36 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 45.04% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 31.32% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | +21.7% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) | +31% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio | 2.72 | Company's total debt divided by total shareholder equity. |
Total Debt | 20.75 Crore | Sum of CARE Ratings's current & long-term financial obligations. |
Total Cash | 86.95 Crore | Total amount of liquid funds available to CARE Ratings. |
Beta | 1.07 | Beta is greater than 1 indicating that the CARE Ratings's price is more volatile than the market. |
Is CARE Ratings A Good Buy For Long Term?
CARE Ratings, a small-cap stock with a market capitalization of ₹4,265.72 crore, shows strong financial health. Its ₹114.36 crore net profit in the last 12 months (TTM), representing a 31.32% profit margin on ₹365.11 crore revenue, is impressive. While Q2 2024-25 data reveals a modest debt of ₹20.75 crore against a cash balance of ₹86.95 crore, the past performance – 44.02% return in the last 3 months and a remarkable 174.22% return over the past 3 years – suggests strong potential. Considering this, CARE Ratings is a good buy for the long term, although individual investment decisions should always be based on a comprehensive analysis.
To predict the CARE Ratings's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
CARE Ratings Share Price Target For 2024
The line chart displays the monthly closing prices of CARE Ratings with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for CARE Ratings shares in 2024, see the table below.
Advertisement
CARE Ratings Share Price Target Table For 2024
CARE Ratings's Levels | Value | Reason/Importance |
---|---|---|
2024 Target 3 | 1478.17 (+3.64%) | Custom Fibonacci Extension Lvl 64.9% |
2024 Target 2 | 1463.00 (+2.57%) | Price Action: 25 Oct 2024 High |
2024 Target 1 | 1445.00 (+1.31%) | Price Action: Oct 2024 Low |
Current Price | 1426.25 | CARE Ratings's 1 share price as of Thu 14 Nov 2024 |
Stop Loss 1 | 1420.03 (-0.44%) | Price Action: Apr 2015 Low |
Stop Loss 2 | 1401.80 (-1.72%) | Price Action: Mar 2015 Low |
Stop Loss 3 | 1387.05 (-2.75%) | Price Action: Jan 2018 High |
Summary: CARE Ratings Share Price Prediction For 2024
In summary, CARE Ratings has surged by ₹474.65, achieving a notable +49.88% increase from 1st January 2024 to 14 Nov 2024. Our analysis of CARE Ratings for 2024 predicts an additional rise of 1.31% to 3.64% by the end of 2024 with three potential targets T1: 1445.00, T2: 1463.00, T3: 1478.17. Stop Loss at SL1: 1420.03, SL2: 1401.80, SL3: 1387.05.
CARE Ratings has a 52-week high of ₹1571.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹840.15, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for CARE Ratings.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
CARE Ratings Share Price Target For 2025
The line chart displays the monthly closing prices of CARE Ratings with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for CARE Ratings shares in 2025, see the table below.
Advertisement
CARE Ratings Share Price Target Table For 2025
CARE Ratings's Levels | Value | Reason/Importance |
---|---|---|
2025 Target 3 | 1900.36 (+33.24%) | Price Action: Chart |
2025 Target 2 | 1864.93 (+30.75%) | Price Action: Chart |
2025 Target 1 | 1846.47 (+29.46%) | Custom Fibonacci Extension Lvl 64.9% |
Current Price | 1426.25 | CARE Ratings's 1 share price as of Thu 14 Nov 2024 |
Stop Loss 1 | 1328.85 (-6.83%) | Price Action: Oct 2016 Low |
Stop Loss 2 | 1314.30 (-7.85%) | Price Action: Jan 2016 High |
Stop Loss 3 | 1297.81 (-9.01%) | Price Action: May 2018 High |
Summary: CARE Ratings Share Price Prediction For 2025
In summary, CARE Ratings has surged by ₹474.65, achieving a notable +49.88% increase from 1st January 2024 to 14 Nov 2024. Our analysis of CARE Ratings for 2025 predicts an additional rise of 29.46% to 33.24% by the end of 2025 with three potential targets T1: 1846.47, T2: 1864.93, T3: 1900.36. Stop Loss at SL1: 1328.85, SL2: 1314.30, SL3: 1297.81.
CARE Ratings has a All-Time high of ₹1805.65, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹840.15, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for CARE Ratings, we have created a specific page for that check here: CARE Ratings Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
CARE Ratings Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of CARE Ratings share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 14.92% over the next 15 years.
For complete year by year CARE Ratings long term share price target from 2024, 2025 to 2039 check the below table.
CARE Ratings Share Price Target Table From 2024, 2025, 2026 to 2039
Year | CARE Ratings Target | YoY Change % |
---|---|---|
2024 | ₹1,426.25 | [Current Price] |
2024 | ₹1,499.65 | 5.14% |
2025 | ₹2,080.86 | 38.75% |
2026 | ₹2,518.05 | 21.01% |
2027 | ₹3,447.32 | 36.9% |
2028 | ₹3,998.19 | 15.97% |
2029 | ₹4,699.91 | 17.55% |
2030 | ₹5,193.13 | 10.49% |
2031 | ₹5,417.02 | 4.31% |
2032 | ₹6,673.34 | 23.19% |
2033 | ₹7,149.84 | 7.14% |
2034 | ₹7,900.17 | 10.49% |
2035 | ₹8,305.4 | 5.12% |
2036 | ₹8,315.99 | 0.12% |
2037 | ₹9,899.36 | 19.04% |
2038 | ₹10,301.49 | 4.06% |
2039 | ₹10,512.66 | 2.04% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
CARE Ratings Past Performance
- In 2013, CARE Ratings opening price was ₹861.65
- As of Thu 14 Nov 2024 the price stands at ₹1,426.25.
- This represents a Compound Annual Growth Rate (CAGR) of 4.29%.
- In 11 years, an investment of 10,000 would have become ₹16,552.54.
As we wrap up, we hope you like our study on CARE Ratings share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.